The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Interaction of Coagulation Defects and Cardiovascular Risk Factors: Increased Risk of Myocardial Infarction Associated With Factor V Leiden or Prothrombin 20210A
Abstract
Background —A genetic variation located in the 3′-untranslated region of the prothrombin gene (prothrombin 20210 G→A) was recently described as a risk factor for venous thrombosis. We examined how the presence of this mutation affected the risk of myocardial infarction in a population-based case-control study. Furthermore, we studied the risk of myocardial infarction associated with the simultaneous presence of a coagulation defect (ie, the 20210 AG genotype of prothrombin or the factor V Leiden mutation) and major cardiovascular risk factors. Methods and Results —Among 560 men with a first myocardial infarction before the age of 70 years, 1.8% were heterozygous carriers of the 20210 variant of the prothrombin gene. The control group consisted of 646 men who were frequency matched by age. In the latter group, the frequency of the 20210 AG genotype was 1.2%. The risk of myocardial infarction in the presence of the AG genotype was increased by 50% (odds ratio, 1.5; 95% confidence interval [95% CI], 0.6 to 3.8). The risk of myocardial infarction for carriership of factor V Leiden mutation was increased by 40% (odds ratio, 1.4; 95% CI, 0.8 to 2.2). When a coagulation defect was present (ie, the 20210 AG prothrombin genotype or the factor V Leiden mutation), the risk of myocardial infarction for carriers versus noncarriers was 1.4 (95% CI, 0.9 to 2.2). This risk was substantially increased when one of the major cardiovascular risk factors of smoking, hypertension, diabetes mellitus, or obesity also was present, with odds ratios varying between 3 and 6. These risks exceeded those of the single effects of the cardiovascular risk factors (ie, in the absence of the coagulation defect). Conclusions —We conclude that in men the 20210 G→A variant of prothrombin is associated with an increased risk of myocardial infarction. The combined presence of major cardiovascular risk factors and carriership of a coagulation defect increases the risk considerably.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Self-citationPoort, Sr., Rosendaal, F., Reitsma, P., & Bertina, R. (1996) · Blood · doi:10.1182/blood.v88.10.3698.bloodjournal88103698 · Cited by 3,079
Self-citationON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE
WOOLF, B. (1955) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01348.x · Cited by 2,723
Koster, T., Vandenbroucke, J., Rosendaal, F., de Ronde, H., Briët, E., & Bertina, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80081-9 · Cited by 1,239
Self-citationLee, K. L., Woodlief, L. H., Topol, E. J., Weaver, W. D., Betriu, A., Col, J., Simoons, M., Aylward, P., Van de Werf, F., & Califf, R. M. (1995) · Circulation · doi:10.1161/01.cir.91.6.1659 · Cited by 1,093
Ridker, P. M., Hennekens, C. H., Lindpaintner, K., Stampfer, M. J., Eisenberg, P. R., & Miletich, J. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321403 · Cited by 1,035
Rosendaal, F., Koster, T., Vandenbroucke, J., & Reitsma, P. (1995) · Blood · doi:10.1182/blood.v85.6.1504.bloodjournal8561504 · Cited by 1,004
Self-citationGeographic Distribution of the 20210 G to A Prothrombin Variant
Doggen, C. J. M., Zivelin, A., Arruda, V. R., Aiach, M., Siscovick, D. S., Hillarp, A., Watzke, H. H., Bernardi, F., Cumming, A. M., Preston, F. E., et al. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615049 · Cited by 696
Self-citationRosendaal, F. R., Siscovick, D. S., Schwartz, S. M., Beverly, R. K., Psaty, B. M., Longstreth, W. T., Raghunathan, T. E., Koepsell, T. D., & Reitsma, P. H. (1997) · Blood · doi:10.1182/blood.v89.8.2817 · Cited by 372
Self-citation
Cited by
Geographic Distribution of the 20210 G to A Prothrombin Variant
Doggen, C. J. M., Zivelin, A., Arruda, V. R., Aiach, M., Siscovick, D. S., Hillarp, A., Watzke, H. H., Bernardi, F., Cumming, A. M., Preston, F. E., et al. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615049 · Cited by 696
Self-citationRole of hemostatic gene polymorphisms in venous and arterial thrombotic disease
Lane, D. A., & Grant, P. J. (2000) · Blood · doi:10.1182/blood.v95.5.1517.005k48_1517_1532 · Cited by 495
Kujovich, J. L. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3181faa0f2 · Cited by 419
Oral Contraceptives and the Risk of Myocardial Infarction
Tanis, B. C., van den Bosch, M. A. A. J., Kemmeren, J. M., Cats, V. M., Helmerhorst, F. M., Algra, A., van der Graaf, Y., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003216 · Cited by 367
Self-citationKim, R. J., & Becker, R. C. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00519-2 · Cited by 342
Metadata
- Authors
- Doggen, C. J. M., Cats, V. M., Bertina, R. M., & Rosendaal, F. R.
- Venue
- Circulation
- Published
- 1998-03-24
- Volume
- 97
- Issue
- 11
- Pages
- 1037-1041
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2096454162
- Cited by
- 259
- References
- 12
- FWCI
- 15.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interaction of Coagulation Defects and Cardiovascular Risk Factors: Increased Risk of Myocardial Infarction Associated With Factor V Leiden or Prothrombin 20210A. https://app.cochat.ai/papers/10.1161/01.cir.97.11.1037
- The paper
- Doggen, C. J. M., Cats, V. M., Bertina, R. M., & Rosendaal, F. R. (1998). Interaction of Coagulation Defects and Cardiovascular Risk Factors: Increased Risk of Myocardial Infarction Associated With Factor V Leiden or Prothrombin 20210A. Circulation. https://doi.org/10.1161/01.cir.97.11.1037
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.